Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Observational × Myasthenia Gravis × Mycophenolic Acid × Clear all

Status

Unknown 1 Recruiting 1

Sponsor Class

OTHER 1 INDIV 1

Study Type

Observational 2 Interventional 2

Sponsor

Conditions

Myasthenia Gravis 2

Interventions

Tacrolimus 3 Pyridostigmine Bromide 3 Prednisone 3 Data Collection 3 ravulizumab 2 efgartigimod alfa 2 Steroids 2 Mycophenolic Acid 2 Blood Specimen Collection 2 Azathioprine 2 Thymectomy 1 Neurofeedback 1 Methylprednisolone 1 Methotrexate 1 Immunosuppressive Agents 1 Immunoglobulins, Intravenous 1 Genotype 1 Diagnostic Self Evaluation 1 Cyclosporine 1 Cyclophosphamide 1 Biomarkers 1 Alleles 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡